ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Correction to "Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.